MEDVi

MEDVi's all-in monthly figures at the maintenance basis are $399 for tirzepatide and $299 for semaglutide, including every mandatory recurring fee, as captured 2026-08-05.

On the current record, tirzepatide runs $399 a month billed monthly; semaglutide runs $299 a month billed monthly. Commitment terms on file: Month-to-month. Longer terms bill as stated at checkout — screenshot the plan page you actually buy from.

Computed from the current record: $4,788 for tirzepatide if billed month to month and $3,588 for semaglutide if billed month to month. The full-year framing is the honest one — the twelve-month cost guide shows why.

Tiered on semaglutide; tirzepatide flat In practice that means the figure you see is the figure you keep as titration proceeds — the structure this site's maintenance-basis ranking rewards.

Cash-pay If you have commercial coverage, Medicare, or Medicaid, run the indication doors before paying cash anywhere — a covered brand pen at a $25–$50 copay beats every cash program on this site.

On record: Partner pharmacies (Partner network). Whatever name appears on your own label is the one to check — the license-verification guide is a fifteen-minute workflow, and the label-reading guide covers the rest.

States served on record: Most US states. State availability shifts with pharmacy licensure and telehealth rules, so the intake screen is the final word — our fifty-one state guides in the Journal record which programs served each state at last review.

No — the program price is all-inclusive with no separate membership.

Status printed on the record — tirzepatide: provider-stated, captured 2026-08-05; semaglutide: provider-stated, captured 2026-08-05. The methodology defines each status, the sources page holds the capture ledger, and a dated checkout screenshot from any reader upgrades a status through the corrections desk.

Cancel before renewal Always screenshot the terms shown at your own checkout; that capture is what governs your plan.

Computed from the plans on record: $4,788 for tirzepatide at the month-to-month rate, no commitment required and $3,588 for semaglutide at the month-to-month rate, no commitment required. Where the figure rides a committed plan, the per-month saving is real and the exit terms matter — read the refund language before prepaying, and note that promotional rates are labeled wherever they apply.

Against the 34 programs with a rankable tirzepatide maintenance price in our database, the median all-in monthly figure is $299; MEDVi's $399 sits above that median. The full computed ranking, promos labeled, is on the cheapest-provider pages.